Merck & Co Inc (NYSE:MRK)

83.80
Delayed Data
As of Oct 17
 -0.65 / -0.77%
Today’s Change
66.10
Today|||52-Week Range
87.35
+9.67%
Year-to-Date
Better Buy: GlaxoSmithKline vs. Merck
Oct 15 / MotleyFool.com - Paid Partner Content
What Happened in the Stock Market Today
Sep 30 / MotleyFool.com - Paid Partner Content
3 Dividend-Paying Pharma Stocks to Buy Now
Oct 15 / MotleyFool.com - Paid Partner Content
Here’s Why Seattle Genetics Stock Jumped Higher Today
Sep 30 / MotleyFool.com - Paid Partner Content
Here's Why Seattle Genetics Climbed 17.6% in September
Oct 07 / MotleyFool.com - Paid Partner Content
Is GlaxoSmithKline a Buy?
Sep 27 / MotleyFool.com - Paid Partner Content
Winners and Losers of Europe’s Big Cancer Meeting
Oct 02 / MotleyFool.com - Paid Partner Content
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Sep 26 / MotleyFool.com - Paid Partner Content
The Medicines Company Surges on Positive Drug Trial Results
Oct 01 / MotleyFool.com - Paid Partner Content
Merck (MRK) Dips More Than Broader Markets: What You Should Know
Sep 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close84.45
Today’s open84.42
Day’s range83.74 - 84.65
Volume6,883,391
Average volume (3 months)9,204,205
Market cap$215.9B
Data as of 6:30pm ET, 10/17/2019

Growth & Valuation

Earnings growth (last year)+165.32%
Earnings growth (this year)+13.16%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+6.17%
P/E ratio23.5
Price/Sales4.82
Price/Book8.19

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.12+0.33%
NVSNovartis+0.23+0.26%
AZNAstraZeneca+0.34+0.78%
SNYSanofi+0.76+1.66%
Data as of 6:30pm ET, 10/17/2019

Financials

Next reporting dateOctober 29, 2019
EPS forecast (this quarter)$1.24
Annual revenue (last year)$42.4B
Annual profit (last year)$6.2B
Net profit margin14.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Kenilworth, New Jersey

Forecasts